Clinical trial

Empagliflozin Effect on Glucose Toxicity

NCT03437330

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2021-10-27

PhasePHASE4

Study timeline

Study start (actual)2021-10-27Date precision: day

Registry last updated2024-05-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetes Mellitusunresolved

Interventions

Empagliflozin (Jardiance®)DRUG

Insulin Glargine (Lantus®)DRUG

Sponsors & collaborators

University Hospital Tuebingenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03437330 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.